maxon Group and Fourier Intelligence have announced that they are entering into a global strategic partnership. maxon's precision drive systems and the start-up Fourier's Intelligence’s rehabilitation robotics are a perfect match and are expected to drive the development of new technologies for patients.
EXOPS X2 with EEG
Fourier’s exoskeleton, ExoMotus™ X2 combining EEG controlling module. Powerful Actuating Unit – a high-performance motor and gearhead to provide a stronger torque output. Credit: maxon Group
Technology plays an increasingly important role in rehabilitation services and healthcare. Therefore, clinicians, engineers and companies recognise that they need to accelerate the development of technological solutions to best meet the needs of patients.
This is the main goal of the partnership between drive specialist maxon and start-up Fourier Intelligence, which specialises in exoskeletons and robotic rehabilitation. The two companies are pooling their expertise to develop industry-leading technologically products and platforms for patient treatment. To seal the partnership, a memorandum of understanding was signed in December 2020.
“The partnership between maxon and Fourier is a powerful combination," said Eugen Elmiger, CEO maxon Group. "Fourier's understanding of the interplay between modern rehabilitation robotics and technological products perfectly complements maxon's philosophy of making the world a little better with our precision drive systems. Together, we will be able to generate industry-leading technology products and platforms.”
Fourier already uses BLDC motors from maxon in its ExoMotus X2 exoskeleton. In addition, maxon will become part of the Exoskeleton & Robotics Open Platform System (EXOPS), an open platform for research and development of exoskeleton and robotics systems. maxon will provide a variety of customized drive solutions with motors, gearheads, encoders and controllers to aspiring engineers who want to develop robotics solutions for rehabilitation services."
Partnering with maxon will allow us to provide the best technology portfolio on which to conceive, design and build the next generation of transformative technological products and platforms," said Zen Koh, co-founder and deputy CEO of Fourier Intelligence. "Together, as one team, we will unlock the full potential of technological rehabilitation and put patients on the best path to recovery."
Back to Homepage
Back to Healthcare
Back to Technology & Innovation